September 17, 2014

Straub Medical's Rotarex S and Aspirex S Catheters Approved in Brazil

September 18, 2014—Straub Medical AG announced that the Brazilian Health Surveillance Agency (ANVISA) has approved the company’s Rotarex S and Aspirex S rotational catheter systems. These endovascular rotational catheters restore blood flow in occluded blood vessels by removing occlusion material from the vessel during endovascular interventions. Straub Medical AG has mandated Tecmedic Produtos Médicos Ltda. in Curitiba with distribution and service of its products in Brazil.

In the company’s press release, Ricardo Aun, MD, commented, “Rotarex S and Aspirex S rotational catheter systems are internationally established standard treatments for arterial and venous occlusive disease. With the ANVISA approval, endovascular specialists throughout Brazil can now use these catheter systems to treat a large variety of vascular occlusions in their patients.” Dr. Aun is a vascular surgeon at Albert Einstein Hospital São Paulo and associate professor in vascular and endovascular surgery at Universidade de São Paulo in São Paulo, Brazil.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

September 17, 2014

Straub Medical's Rotarex S and Aspirex S Catheters Approved in Brazil

Current Issue

Keep In Touch